signifikant reduceret fra 14, 0% for placebo til 11, 3% (hazard rate 0, 80; 95% CI 0, 69- 0, 93; p = 0, 003).
e the incidence of death/ re-MI at Day 30 was significantly reduced from 14.0% on placebo to 11.3% (hazard ratio 0.80, 95% CI, 0.69, 0.93, p = 0.003).